Transcranial sonography depicts a larger substantia nigra echogenic area in renal transplant patients on calcineurin inhibitors than on rapamycin

BACKGROUND: After kidney transplantation neurologic manifestations may develop, including Parkinson’s disease (PD). An enlarged substantia nigra (SN) by transcranial sonography has been recognized as a marker of PD. METHODS: In renal transplant recipients (RTRs = 95) and controls (n = 20), measureme...

Descripción completa

Detalles Bibliográficos
Autores principales: Araújo, Nordeval Cavalcante, Suassuna, José Hermógenes Rocco, Fernandes, Rita de Cássia Leite
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931960/
https://www.ncbi.nlm.nih.gov/pubmed/35300603
http://dx.doi.org/10.1186/s12882-022-02741-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931960/
https://www.ncbi.nlm.nih.gov/pubmed/35300603
http://dx.doi.org/10.1186/s12882-022-02741-7

Ejemplares similares